SGLT2 Inhibitors and Renal Anemia in Japan: RWD

NCT07063316 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

15000

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease

Interventions

DRUG: SGLT2 inhibitor

Sponsor

Boehringer Ingelheim

Collaborators

[object Object]